Commodore Capital LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001831942

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2024 · 39 positions · Total reported value $1.50B · Top-10 concentration 60.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 53.7% · 5 new · 9 cut · 8 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +32.0% · vs SPY +17.2% · Prev Value $1.73B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2024 13F filing, Commodore Capital LP disclosed 39 equity positions with a combined reported value of $1.50B. The filing implies a focused portfolio: its ten largest positions account for 60.2% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were MRUS ($196.33M), VERA ($136.47M), NUVL ($111.72M). By sector, the heaviest allocations are Health Care 68.6%, Other 31.4%.

Versus the prior quarter, Commodore Capital LP opened 5 new positions, trimmed 9 and fully exited 8, a turnover rate of 53.7% of positions. The portfolio's overlap with the prior quarter was 65% of names.

The largest new positions opened in Q1 2024 were MNMD ($54.83M), ORIC ($27.50M), CATX ($25.05M).

Of the 8 positions fully exited versus the prior quarter, the largest were RYZB ($23.85M), HARP ($17.05M), AKRO ($13.19M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • MNMD MIND MEDICINE MINDMED INC · $54.83M
  • ORIC ORIC PHARMACEUTICALS INC · $27.50M
  • CATX PERSPECTIVE THERAPEUTICS INC · $25.05M
  • KYTX KYVERNA THERAPEUTICS INC · $22.66M
  • ENGN ENGENE THERAPEUTICS INC · $21.19M
  • AUTL AUTOLUS THERAPEUTICS LTD · $14.67M
  • NGNE NEUROGENE INC COM · $10.18M
  • SNDX SYNDAX PHARMACEUTICALS INC · $7.59M

Fully Exited (vs previous quarter)

  • RYZB RAYZEBIO INC · prev qtr: $23.85M
  • HARP HARPOON THERAPEUTICS INC · prev qtr: $17.05M
  • AKRO AKERO THERAPEUTICS INC · prev qtr: $13.19M
  • DYN DYNE THERAPEUTICS INC · prev qtr: $11.97M

Insider Transactions (Form 4)

Latest Commodore Capital LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Commodore Capital LP, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 33 positions worth $1.68B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-117168 (status: Approved), registered 2019-08-12
  • Regulatory AUM (Form ADV): $2.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: commodorecapital.com

Portfolio Structure

  • 33 positions · $1.68B reported value (Q2 2026)
  • Top 10 holdings = 68.2% of reported value
  • Largest position: RLAY (RELAY THERAPEUTICS INC COM) at 13.4%
  • Average position size: $50.88M

Sector Tilt

  • Health Care 94.7%
  • Industrials 3.9%
  • Financials 0.6%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 5 new, 6 added, 9 reduced, 8 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 68.6%
Other 31.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 4.36M $196.33M 13.13%
13.13%
Reduce
2 3.17M $136.47M 9.13%
9.13%
Reduce
3 1.49M $111.72M 7.47%
7.47%
Add
4 2.17M $93.32M 6.24%
6.24%
Hold
5 1.88M $71.46M 4.78%
4.78%
Hold
6 3.97M $69.89M 4.67%
4.67%
Add
7 860.00K $58.75M 3.93%
3.93%
Reduce
8 5.83M $54.83M 3.67%
3.67%
New
9 1.38M $54.51M 3.65%
3.65%
Reduce
10 1.27M $52.63M 3.52%
3.52%
Add
11 1.05M $45.50M 3.04%
3.04%
Reduce
12 6.42M $43.18M 2.89%
2.89%
Add
13 1.73M $39.86M 2.67%
2.67%
Add
14 866.47K $36.37M 2.43%
2.43%
Add
15 3.17M $34.21M 2.29%
2.29%
Add
16 1.93M $33.88M 2.27%
2.27%
Add
17 1.56M $33.61M 2.25%
2.25%
Reduce
18 1.52M $32.53M 2.17%
2.17%
Add
19 3.41M $27.86M 1.86%
1.86%
Reduce
20 2.00M $27.50M 1.84%
1.84%
New
21 1.90M $27.10M 1.81%
1.81%
Hold
22 21.05M $25.05M 1.68%
1.68%
New
23 750.99K $24.26M 1.62%
1.62%
Reduce
24 912.19K $22.66M 1.51%
1.51%
New
25 1.25M $21.19M 1.42%
1.42%
New
26 290.00K $19.27M 1.29%
1.29%
Add
27 1.10M $18.77M 1.25%
1.25%
Reduce
28 2.30M $14.67M 0.98%
0.98%
New
29 1.25M $11.80M 0.79%
0.79%
Add
30 200.00K $10.18M 0.68%
0.68%
New
31 657.33K $9.29M 0.62%
0.62%
Reduce
32 1.57M $8.32M 0.56%
0.56%
Hold
33 318.85K $7.59M 0.51%
0.51%
New
34 169.53K $7.26M 0.48%
0.48%
Reduce
35 500.00K $5.20M 0.35%
0.35%
New
36 295.02K $4.34M 0.29%
0.29%
New
37 1.37M $3.23M 0.22%
0.22%
New
38 183.17K $831.61K 0.06%
0.06%
Reduce
39 92.69K $69.43K 0.01%
0.01%
Hold

FAQ

What did Commodore Capital LP buy in 2024-Q1?

In its 2024-Q1 13F filing, Commodore Capital LP reported 39 equity positions worth $1.50B in aggregate; its largest disclosed positions were MRUS ($196.33M), VERA ($136.47M), NUVL ($111.72M).

How large is Commodore Capital LP's portfolio?

Commodore Capital LP reported $1.50B of long equity holdings across 39 positions as of 2024-Q1. Top-10 holdings account for 60.2% of reported value.

What is Commodore Capital LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/commodore-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →